Conclusions and Relevance
cancer
CANCER, STILL
Apps are inexpensive and scalable tools that can provide additional support for individuals coping with complex cancer treatments. This trial provides evidence that a well‐designed oncology support app used during chemotherapy resulted in fewer clinic visits. Still, nearly a quarter of participants randomized to the intervention arm reported never using the app due to personal preference and usability challenges, which points to future opportunities for calibrating target user population and improving user‐centered design.Clinicaltrials.gov identifier: NCT04331678.This randomized controlled trial of oncology patients provides evidence that a well‐designed oncology support mobile app used during chemotherapy resulted in fewer clinic visits.
